GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BELLUS Health Inc (TSX:BLU) » Definitions » Float Percentage Of Total Shares Outstanding

BELLUS Health (TSX:BLU) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 05, 2024)


View and export this data going back to 2000. Start your Free Trial

What is BELLUS Health Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, BELLUS Health's float shares is 0.00 Mil. BELLUS Health's total shares outstanding is 126.81 Mil. BELLUS Health's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, BELLUS Health's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, BELLUS Health's Institutional Ownership is 10.44%.

BELLUS Health Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

BELLUS Health's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/126.81
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BELLUS Health (TSX:BLU) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BELLUS Health Inc (TSX:BLU) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
TSX:FRX TSX:SVA TSX:ONC NEOE:MMED TSX:EPRX XCNQ:DTC TSX:BCT TSXV:ARCH TSX:TH TSXV:NGEN OCSE:NOVO B ASX:CSL VRTX REGN MRNA XKRX:207940 SGEN BNTX OCSE:GMAB ALNY
Traded in Other Exchanges
N/A
Address
275 Armand-Frappier Boulevard, Laval, QC, CAN, H7V 4A7
Website
http://www.bellushealth.com
BELLUS Health Inc is a clinical-stage biopharmaceutical development company advancing novel therapeutics for conditions with a high unmet medical need, including BLU-5937, a P2X3 antagonist that has the potential to be a best-in-class therapeutic for chronic cough. The company operates in one business segment namely, the development of drug candidates for health solutions.